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Summary 9 
Adult hippocampal neurogenesis is strongly dependent on thyroid hormone (TH). Whether TH 10 
signalling regulates this process in a cell-autonomous or non-autonomous manner remains 11 
unknown. To answer this question, we used global and conditional knock-outs of the TH 12 
transporter monocarboxylate transporter 8 (MCT8), having first employed FACS and 13 
immunohistochemistry to demonstrate that MCT8 is the only TH transporter expressed on 14 
neuroblasts and adult slice cultures to confirm a necessary role for Mct8 in neurogenesis. Both 15 
mice with a global deletion or an adult neural stem cell-specific deletion of MCT8 showed 16 
decreased expression of the cell-cycle inhibitor P27KIP1, reduced differentiation of 17 
neuroblasts and impaired generation of new granule cells neurons, with global knock-out mice 18 
also showing enhanced neuroblast proliferation. Together, our results reveal a cell-19 
autonomous role for TH signalling in adult hippocampal neurogenesis alongside non-cell 20 
autonomous effects on cell proliferation earlier in the lineage.  21 
 3 
Introduction 22 
 23 
Adult hippocampal neurogenesis is a highly orchestrated process with cells passing 24 
through distinct stages to generate granule cell neurons (GCNs) throughout life 25 
(Beckervordersandforth et al., 2015; Kempermann et al., 2004; Remaud et al., 2014). This 26 
process is initiated from neural stem cells (NSCs) in the subgranular zone (SGZ) that cycle 27 
between quiescence and an activated state in which they generate transiently amplifying 28 
precursors (TAPs) from which new postmitotic neurones are formed via an intermediate 29 
neuroblast (NB) state. These newly formed neurons eventually integrate into the existing 30 
dentate gyrus granule cell network thereby creating new connections that contribute to CNS 31 
plasticity.  32 
A link between hippocampal neurogenesis and cognitive function is well-established 33 
and adult-onset hypothyroidism is known to result in cognitive perturbations such as learning 34 
and memory deficits (Correia et al., 2009; Miller et al., 2006; Osterweil et al., 1992; Remaud 35 
et al., 2014). In light of this, a number of studies have investigated if TH deficiency impairs the 36 
hippocampal neurogenic process. These studies have consistently demonstrated an effect on 37 
progenitor differentiation and the generation of neurons, but no consistent effects earlier in the 38 
lineage on NSC behaviour (Ambrogini et al., 2005; Desouza et al., 2005; Montero-Pedrazuela 39 
et al., 2006). However, a key question that remains unanswered is whether this effect results 40 
from a cell autonomous requirement for TH signalling within the hippocampal lineage or from 41 
an indirect, non-cell autonomous effect resulting from TH function in supporting glial and other 42 
cell types. Addressing this is important to identify the necessary cellular targets for therapies 43 
designed to treat age-related cognitive decline based on modulated TH signalling. 44 
One strategy to address this question is to identify essential components of the TH 45 
signalling pathway selectively expressed in NBs and then compare the effects of global and 46 
conditional knock-outs of these components. The latter will reveal only cell autonomous 47 
effects, while the former will reveal both cell and non-cell autonomous effects. By examining 48 
the cellular expression pattern of components of the TH signalling pathway throughout the 49 
 4 
adult hippocampal neurogenic program we identified such a component, the TH transporter 50 
MCT8. Transgenic mice lacking MCT8 either globally or just in the hippocampal neurogenic 51 
lineage both showed impaired differentiation of NBs and a reduced formation of new GCNs in 52 
the adult hippocampus. This impairment is associated with an improper regulation of the cell 53 
cycle inhibitor P27KIP1 in neural progenitors. We conclude that the effect of TH on the 54 
generation of neurons from NBs is cell-autonomous and that MCT8 is a critical gate-keeper for 55 
this step of hippocampal neurogenesis.   56 
 5 
Results 57 
 58 
Differential expression of TH signalling components within the hippocampal neurogenic 59 
lineage 60 
  61 
TH signalling in the CNS is regulated at several levels. First, TH transporters such as 62 
the L-type amino acid transporters (LAT) 1 and 2, organic anion transporting polypeptide 63 
(OATP) 1C1 and monocarboxylate transporters (MCT) 8 and 10  are mandatory for TH 64 
transmembrane passage across the blood-brain-barrier (BBB) and cellular TH uptake (Bernal 65 
et al., 2015; Heuer and Visser, 2013). Second, intracellular iodothyronine deiodinases (DIO) 66 
then either activate (DIO2) or inactivate TH (DIO3) (Bianco et al., 2002). Third, µ-Cristallin 67 
(CRYM), a cytosolic TH binding protein, can regulate intracellular TH levels (Suzuki et al., 68 
2007). Fourth, nuclear TH receptors (TRs) encompassing the ligand binding isoforms TRα1, 69 
TRβ1 and TRβ2 as well as non-ligand binding isoforms like TRα2 regulate gene expression in 70 
response to TH (Flamant and Gauthier, 2013; Koenig et al., 1989). Last, co-activators or co-71 
repressors are recruited to TR isoforms, including NCOR (nuclear receptor corepressor; 72 
NCOR1) and SMRT (silencing mediator of retinoid and thyroid hormone receptors; NCOR2) 73 
(Astapova and Hollenberg, 2013).  74 
To unravel the temporal expression pattern of these TH signalling components in the 75 
adult mouse hippocampus and identify any selectively expressed in NBs, we micro-dissected 76 
and dissociated dentate gyri for FACS. We used intracellular markers to isolate different 77 
progenitor/neuronal populations that develop in sequence within the hippocampal neurogenic 78 
lineage (Kempermann et al., 2004) (Fig.1A). The first cell population comprises NSCs that are 79 
located in the SGZ of the dentate gyrus, extend a radial process into the molecular layer and 80 
are positive for glia fibrillary acidic protein (GFAP), SRY-Box 2 (SOX2) and NESTIN. The 81 
second population encompasses TAPs (intermediate progenitors; type 2a and type 2b 82 
progenitors) which express the transcription factor T-box brain protein 2 (TBR2) and are 83 
generated by asymmetrical division of activated NSCs. This population can be subdivided by 84 
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expression of the neuronal differentiation-promoting factor PROX1 (Prospero Homeobox 1) 85 
and the immature neuronal marker Doublecortin (DCX) in type 2b progenitors. Cells of the third 86 
population, DCX+ type 3 NBs, develop a vertical process whilst exiting the cell cycle to 87 
generate, fourth, immature post-mitotic neurons (INs) which are characterized by transient 88 
expression of the Calcium-binding protein Calretinin (CR). Finally, the fifth population 89 
comprises GCNs in which Dcx and CR expression cease and Calbindin (CB) expression is 90 
initiated. 91 
 Using forward and side scatter, we separated cells (P1; 2.1-8.0%) from debris and 92 
selected single cells (P2; 94.9-98.9%) (Fig.S1A). Single cells viable before fixation were 93 
identified based on a low intensity of a fixable live/dead cell stain (P3; 38.4-53.4%). From those 94 
cells, a TBR2+ population was isolated (0.6-2.3%) (Fig.S1B). The TBR2- population (P4) was 95 
then subdivided into a DCX- and a DCX+ population (4.1-7.8%). The latter was then sorted 96 
into CR- NBs (51.1-92.4%) and into CR+ INs (5.9-42.6%). In a second sorting strategy, CB+ 97 
GCNs (5.5-21.3%) were isolated from live cells (P3) (Fig.S1C). From the CB- population (P4) 98 
NESTIN+/GFAP+ NSCs were sorted (1.1-5.2%). All other cells were collected for RIN value 99 
determination. To preserve RNA integrity, we performed staining and sorting steps at low 100 
temperatures and in the presence of RNase inhibitor. As shown in Fig.S1D comparing the RIN 101 
value of a fixed sample, a fixed/stained sample and cells undergoing the staining/sorting 102 
procedure, a RIN value of 7.0 or higher was reached with our measures.  103 
 We then performed qPCR on isolated populations after mRNA amplification. To 104 
validate the identity of the isolated cell populations, neurogenic marker expression was 105 
analysed (Fig.1B). The stem cell marker Hes5 (Beckervordersandforth et al., 2015) was 106 
strongly expressed in NSCs. As expected, we found high Dcx mRNA expression in TAPs, NBs 107 
and INs. Prox1 transcript was expressed in NB, IN and GCN samples. NeuN mRNA, though 108 
detectable in TAP and NB, was highly enriched in GCN samples. A NSC, NB and GCN sample 109 
were also used for RT-PCR (Fig.S1E). Dcx was again enriched in the NB population, while the 110 
lineage marker Prox1 was found in both NBs and GCNs.  111 
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 Next, we assessed the mRNA expression profile of TH signalling components. Within 112 
the TH transporters (Fig.1C), we observed Mct8 transcripts primarily in NBs and GCNs while 113 
Mct10 mRNA was enriched in mature neurons. Lat1 and Lat2 expression was detected in 114 
NSCs and TAPs, whereas only Lat2 was further enriched in GCNs. Analysis of TR expression 115 
profiles revealed Trα1, Trα2, Trβ1 and Trβ2 transcripts in the hippocampal lineage (Fig.1D). 116 
While both Trα isoforms and Trβ1 mRNAs were predominantly expressed in NSC, NB and 117 
GCN populations, Trβ2 transcript levels were down-regulated upon neuronal maturation. 118 
Finally, Crym, Dio3, Ncor and Smrt exhibited a similar profile of transcripts with peaks in NB 119 
and GCN stages (Fig.1E) matching the expression of Mct8, Trα1 and Trα2. Of note, Oatp1c1, 120 
Dio1 and Dio2 transcripts were not detected in the analysed cell populations.  121 
To complement our qPCR analysis, we performed immunofluorescence studies using 122 
perfusion-fixed brain cryosections from 2-month-old animals and commercially available 123 
antibodies against DIO3, LAT1, LAT2, MCT8 and MCT10 in combination with cell-type specific 124 
markers. (Fig.2). In contrast to our qPCR results LAT1 co-localized only with the endothelial 125 
cell marker CD31/PECAM-1 throughout the dentate gyrus (Fig.S2) while none of the proteins 126 
above could be detected in GFAP+/SOX2+ NSCs (Fig.2A). No co-localisation with the 127 
proliferation marker MCM2 present in activated NSCs, TAPs and cycling NBs was observed 128 
for any component except MCT8, which was found in a specific subset of MCM2+ cells also 129 
expressing DCX (Fig.2B). By employing a triple staining protocol, we observed strong 130 
expression of MCT8 protein in DCX+/CR- NBs and in DCX+/CR+ INs (Fig.2A) while none of 131 
the other proteins showed detectable expression at this stage. In agreement with our qPCR 132 
results, CB+ GCNs were positive for DIO3, LAT2, MCT8, and MCT10 protein. Whereas MCT8 133 
and MCT10 exhibited equal expression throughout the granule cell layer, an asymmetrical 134 
pattern was found for DIO3 and LAT2 with stronger signals in the region contacting the 135 
molecular layer of the hippocampus (Fig.2C). We conclude that MCT8 is present in NBs, while 136 
later stages of the lineage contain a wider range of transporters. As TH transporters are 137 
essential for TH signalling, this finding identifies MCT8 as a possible target for our global and 138 
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conditional knock-out strategy to define the cell autonomy of TH signalling during the 139 
generation of neurons from NBs.  140 
 141 
Inhibition of MCT8 reduces the formation of new neurons in adult hippocampal slices  142 
  143 
Before generating transgenic mice, we sought to confirm a functional role for MCT8 in 144 
hippocampal neurogenesis using commercially available inhibitors in vitro. For that purpose, 145 
we established a protocol to maintain adult hippocampal slices for at least three weeks by 146 
combining different published protocols (Kim et al., 2013; Kleine Borgmann et al., 2013) and 147 
adding Indomethacin for its protective effects on neurogenesis in vivo and ex vivo (Gerlach et 148 
al., 2016; Melo-Salas et al., 2018). As a readout, we performed EdU tracing studies together 149 
with KI67 labelling to quantify progenitor proliferation, DCX labelling to quantify type 2b 150 
progenitors, NBs and INs and NEUN staining for neurons (Fig.3A).   151 
Incubation with the MCT8-specific inhibitor Silychristin (Johannes et al., 2016) for 24 h 152 
did not alter proliferation in the SGZ (Fig.S3A) or the number of EdU+ and KI67+/EdU+ cells 153 
(Fig.3B and C). By 7 days in culture a trend towards decreased formation (EdU+, Fig.3D) and 154 
proliferation (KI67+/EdU+, Fig.S3A) of DCX+ cells in Silychristin-treated slices was seen, while 155 
longer incubation with the inhibitor resulted in a significant reduction of newly formed neurons 156 
(NEUN+/EdU+) after 21 days (Fig.3E). By contrast, treatment of hippocampal slices with the 157 
LAT inhibitor BCH (Ritchie et al., 1999; Ritchie et al., 2003) or the deiodinase inhibitor iopanoic 158 
acid (Dentice et al., 2013) had no effect on proliferation or NB and neuron formation (Fig.S3B 159 
and C). These inhibitor studies point to a crucial role of MCT8 during later stages of 160 
hippocampal neurogenesis. 161 
  162 
Absence of MCT8 in vivo compromises adult hippocampal neurogenesis 163 
 164 
Having confirmed a functional role for MCT8 in vitro, we assessed the consequences 165 
of global inactivation of MCT8 in vivo. At the age of 2 months, overall NSC numbers (defined 166 
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as GFAP+/SOX2+ cells extending a radial process into the granule cell layer) were the same 167 
in MCT8ko and Wt littermates. However, NSC activation was impaired in MCT8ko mice as 168 
significantly fewer NSCs were labelled by the proliferation marker KI67 (Fig.4A). Total numbers 169 
of KI67+ progenitors and the density of KI67+/DCX+ type 2b and type 3 progenitors were 170 
similar between the genotypes (Fig.4B). Likewise, no difference in the number of TBR2+ TAPs 171 
(Fig.S4A), cleaved CASPASE3+ apoptotic cells (Fig.S4B) and DCX+/CR- NBs (Fig.4C) could 172 
be observed. In contrast, a significantly reduced number of DCX+/CR+ INs was found in the 173 
MCT8ko SGZ (Fig.4C) pointing to impaired differentiation. 174 
 To explore the dynamics of neurogenesis further, we performed EdU label-retention 175 
studies. We injected 2-month-old mice with EdU and followed the formation of progenitor cells 176 
and neurons by NSCs in the hippocampus (Fig.4D) either at day 3 post injection (3 dpi) to 177 
examine the level of proliferation within each population or 28 dpi to quantify the number of 178 
labelled cells that are fully differentiated. At 3 dpi, we detected significantly more EdU labelled 179 
KI67+/DCX+ progenitors and DCX+/CR- NBs in MCT8ko mice compared to Wt littermates 180 
(Fig.4E and 4F respectively) whereas numbers of DCX+/CR+/EdU+ newly formed INs were 181 
not different (Fig.4F). At 28 dpi, significantly fewer EdU+/CB+ GCNs were seen in MCT8ko 182 
mice (Fig.4G) demonstrating that dividing NBs exhibit differentiation impairments in the 183 
absence of MCT8. 184 
 Hippocampal neurogenesis is highly active in young animals and rapidly declines with 185 
age, being already greatly compromised around half a year of age (Ben Abdallah et al., 2010; 186 
Kuhn et al., 2018). We wondered if the deficits resulting from loss of MCT8 are also observed 187 
at older ages when the number of cells transitioning from NB to neuron populations is reduced. 188 
To address this, we repeated our analysis at 6 months using the same EdU injection paradigm 189 
as in Fig.4D. At this age, MCT8ko mice exhibited a slight but significantly increased density of 190 
GFAP+/SOX2+ cells with a radial process in the SGZ, while similar numbers of NSCs were 191 
labelled with KI67 (Fig.5A). No differences were observed in the number of TBR2+ TAPs 192 
(Fig.S5A), cleaved CASPASE3+ apoptotic cells (Fig.S5B) or the total number of KI67+ cells. 193 
While the increase in KI67+/DCX+ cells did not reach statistical significance (Fig.5B), the 194 
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number of DCX+/CR- cells in the SGZ (comprising NBs and type 2b cells) was almost doubled 195 
in MCT8ko mice (Fig.5C). In contrast, MCT8ko mice demonstrated a severely reduced 196 
formation of new GCNs (CB+/EdU+) when assessed at 28 dpi (Fig.5D). We conclude that the 197 
deficit in neuron differentiation is also present in older animals despite the overall reduction in 198 
neurogenesis. 199 
 As a second approach to follow the progeny of dividing NSCs, we employed a stable 200 
labelling strategy by generating Wt and MCT8ko mice expressing a Nestin-CreERT2 construct 201 
and a tdTomato reporter (hereafter Rfp) (Fig.5E). Following 5 consecutive days of tamoxifen 202 
treatment at the age of 4 weeks, mice were kept for 5 months before analysis, so matching the 203 
6 month-time point used in the EdU analysis above. A similar absolute number of NSCs were 204 
labelled in both genotypes, though their relative contribution to all RFP+ cells was significantly 205 
higher in MCT8ko mice (Fig.5F). Despite this, and in agreement with our EdU incorporation 206 
studies, the relative number of NSC-derived RFP+/CB+ cells amongst all RFP+ cells was 207 
significantly reduced in MCT8ko mice. Together, our experiments using different labelling 208 
techniques and ages confirm that the absence of MCT8 and thus the loss of TH transporter 209 
activity in NBs inhibits the generation of new GCNs in the dentate gyrus.  210 
 211 
The deficit in neuron formation caused by MCT8 loss is cell-autonomous 212 
 213 
These deficits in neurogenesis may result from cell-autonomous effects of MCT8 214 
deletion in hippocampal NBs. Alternatively, the well-described endocrine alterations following 215 
global loss of MCT8 such as high serum T3 and low serum T4 levels and/or impaired transport 216 
of T3 across the blood-brain barrier (BBB) that in turn causes a mild central TH deficiency 217 
(Ceballos et al., 2009; Trajkovic et al., 2007) may impact NB differentiation and GCN formation. 218 
To distinguish between these possibilities, we generated a mouse model with specific deletion 219 
of MCT8 in the adult neurogenic lineage (Fig.6A). To this end, Mct8+/fl females were mated 220 
with males heterozygous for the Nestin-CreERT2 allele and homozygous for a tdTomato 221 
reporter allele (hereafter Rfp) (Fig.6A). Mct8+/y,Nestin-CreERT2/+,Rfp/+ (control) and 222 
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Mct8fl/y,Nestin-CreERT2/+,Rfp/+ (MCT8-NSCko) mice were used. Tamoxifen-induced Cre-223 
activation at 1 month of age resulted in RFP expression and deletion of MCT8 in MCT8-NSCko 224 
animals in adult NSCs and thus the neurogenic lineages only as confirmed by the loss of MCT8 225 
expression in RFP+ neurons in MCT8-NSCko mice (Fig.S6A). All analyses were performed 5 226 
months later to match the 6-month time point of global MCT8ko mice which showed GCN 227 
formation impairments and higher NB numbers. Again, we corrected our analysis for 228 
differences between individual animals by normalizing cell counts to the overall number of 229 
RFP+ cells. We found no differences in the percentage of RFP+ NSCs (Fig.6B), activated 230 
NSCs (GFAP+/RFP+/KI67+/radial process; Fig.6C), proliferating cells (KI67+/RFP+), 231 
proliferating type 2b cells/NBs (DCX+/KI67+/RFP+) (Fig.6D), TBR2+/RFP+ TAPs (Fig.S6B) 232 
and apoptotic cells (CASPASE3+/RFP+; Fig.6E). In contrast to age-matched global MCT8ko 233 
mice where NB numbers were increased, we detected a similar number of NBs (DCX+/CR-234 
/RFP+) in MCT8-NSCko and controls at 6 months of age alongside a trend towards fewer INs 235 
(DCX+/CR+/RFP+) (Fig.6F). As in global MCT8ko mice, however, the relative number of 236 
CB+/RFP+ GCNs was significantly decreased in MCT8-NSCko (Fig.6G), confirming a cell-237 
autonomous role of MCT8 within the hippocampal neurogenic lineage. 238 
 239 
Expression of the cell cycle inhibitor P27KIP1 is impaired in MCT8 deficiency 240 
 241 
One mechanism by which TH induces differentiation is by suppression of the cell cycle 242 
(Remaud et al., 2014), with direct regulation of cell cycle inhibitors such as Cyclin-dependent 243 
kinase inhibitor 1B (CDKN1B; P27KIP1) (Garcia-Silva et al., 2002; Holsberger et al., 2003). To 244 
examine this mechanism in the hippocampal neurogenic lineage, we quantified P27KIP1 levels 245 
in DCX+/CR- NBs and DCX+/CR+ INs in 2-month-old Wt and MCT8ko mice (Fig.7A). We 246 
discovered significantly reduced P27 fluorescence intensities in both cell populations in 247 
MCT8ko animals and replicated this finding in both 6-month-old MCT8ko mice (Fig.7B), and 6 248 
months old MCT8-NSCko mice (Fig.7C). As the CIP/KIP family of cell cycle/CDK inhibitors 249 
comprises two more members, P21CIP1/WAF1 and P57KIP2, we assessed their expression 250 
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in 2 and 6 months old Wt and MCT8ko mice, but failed to observe differences in P21 (Fig.7D 251 
and E respectively) and P57 (Fig.7F and G respectively) immunofluorescence levels. Likewise, 252 
p27kip1/Dcx transcript ratios were reduced in micro-dissected dentate gyri from 6-month-old 253 
MCT8ko mice while p57 mRNA levels were not different (Fig.S7). In sum, our results show a 254 
specific decrease in P27KIP1 following loss of MCT8 in the hippocampal neurogenic lineage, 255 
which likely underlies the impaired differentiation capacities in MCT8 deficiency.    256 
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Discussion 257 
 258 
Patients with adult-onset hypothyroidism show specific defects in hippocampal memory 259 
function and a decreased hippocampal volume (Cooke et al., 2014; Correia et al., 2009; 260 
Ittermann et al., 2018). These clinical findings may be explained by a profound impact of TH 261 
on hippocampal neurogenesis, a process imperative for learning and memory, as animal 262 
experiments have confirmed that TH deficiency delays neuronal differentiation and perturbs 263 
the birth of new GCN in the adult hippocampus (Ambrogini et al., 2005; Desouza et al., 2005; 264 
Montero-Pedrazuela et al., 2006). However, the widespread systemic effects of TH deficiency 265 
make it impossible from these experiments using globally hypothyroid animals to resolve the 266 
key question if TH signalling impairs neuroblast differentiation cell-autonomously. Here, we 267 
demonstrate such a cell-autonomous effect by using a conditional knock-out strategy following 268 
a comprehensive analysis of the cell-specific repertoire of TH transporters, receptors, and 269 
metabolizing enzymes during hippocampal neurogenesis. A combination of FACS and qPCR 270 
allowed us to analyse distinct cell populations within the neurogenic program. With this 271 
approach, we could confirm the presence of Trα, Trβ1 and Trβ2 transcripts in cycling 272 
progenitors and GCNs as well as Trα1 expression in DCX+ progenitors as described before 273 
(Desouza et al., 2005; Kapoor et al., 2010). We also demonstrated the presence of DIO3 and 274 
the TH transporters LAT2, MCT8, and MCT10 in GCNs. Critically, however, of all TH 275 
transporters analysed only MCT8 was found to be expressed in NBs at both the mRNA and 276 
protein level, suggesting a distinct function within the TH-regulated neurogenic program and 277 
enabling its manipulation as a means of addressing the central question of this study.  278 
To our knowledge, this is the first study using a conditional knock-out strategy to 279 
investigate TH signalling in the hippocampal lineage. The importance of this approach is 280 
highlighted by a comparison with a global MCT8ko mouse model. The critical role of MCT8 in 281 
transporting T3 and T4 across brain barriers (Bernal et al., 2015; Ceballos et al., 2009; 282 
Trajkovic et al., 2007) means that the brain of global MCT8ko mice is in a mild hypothyroid 283 
state, affecting TH metabolism and regulation of TH target genes. That this causes non-cell 284 
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autonomous effects on neurogenesis is shown by our finding that at 6 months of age the 285 
number of NBs was not altered in MCT8-NSCko mice while it was increased in global MCT8ko 286 
mice. This increase cannot simply be explained by a hypothyroid neurogenic niche due to a 287 
global loss of MCT8. Both TRα1 mutant mice that show features of a hypothyroid CNS and 288 
globally hypothyroid animals exhibit a reduced number of DCX+ cells in the SGZ (Kapoor et 289 
al., 2010; Montero-Pedrazuela et al., 2006) while a rise in NB numbers was reported in 290 
TRα1ko, hyperthyroid TRβko or T3-treated  mice (Kapoor et al., 2012; Kapoor et al., 2011; 291 
Kapoor et al., 2010). In the latter model, increased BrdU-labelling of DCX+ cells was attributed 292 
to earlier acquisition of DCX immunoreactivity (Kapoor et al., 2012). The increased EdU 293 
labelling in DCX+ cells we observe in MCT8ko animals may be explained in the same way, 294 
linked to the hyperthyroid periphery of MCT8ko mice (Trajkovic et al., 2007). In keeping with 295 
this, we do not see earlier DCX expression in slices treated with a MCT8 inhibitor, where the 296 
level of TH in the culture medium is normal. However, alterations in cell cycle entry or kinetics 297 
cannot be fully excluded.  298 
Non-cell autonomous effects earlier in the lineage may also explain the differences 299 
observed in NSC and NB numbers at 2 and 6 months between MCT8ko and Wt animals. 300 
Reduced NSC activation in the global ko at 2 months (which as it is not seen in the MCT8-301 
NSCko mice must be a non-cell autonomous effect of TH signalling) would be expected to 302 
preserve the NSC population and so explain the increased NSCs present in the MCT8ko at 6 303 
months as compared to Wt mice at the same age. This in turn could attenuate the normal age-304 
related decline in NBs (as would the earlier DCX expression discussed above), so explaining 305 
the smaller reduction in NBs at 6 months in these mice. Clearly, any of the neighbouring glial 306 
and vascular cell types could contribute to this non-cell autonomous effect. We hypothesise, 307 
however, that MCT8 deficient astrocytes contribute significantly through the previously 308 
described effects on TH-regulated components of the NOTCH or WNT signalling pathways 309 
(Morte et al., 2018). 310 
The role of MCT8 at the differentiation stage of neurogenesis is of particular relevance 311 
to the pathophysiology of Allan-Herndon-Dudley syndrome (AHDS), a severe form of 312 
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psychomotor retardation caused by inactivating mutations in MCT8 (Dumitrescu et al., 2004; 313 
Friesema et al., 2004; Schwartz et al., 2005). AHDS-like symptoms could be replicated only 314 
by simultaneous inactivation of MCT8 and another TH transporter, OATP1C1, in mice (Mayerl 315 
et al., 2014), from which we presumed that impaired TH transport across the BBB and/or 316 
BCSFB is the major abnormality driving the disease phenotype. Our results that MCT8 loss 317 
results in cell autonomous effects in NBs, however, suggests that a direct effect on the 318 
formation of newly-born GCNs may also contribute to the phenotype. 319 
MCT8 has recently been implicated in corticogenesis in the chicken optic tectum 320 
(Vancamp et al., 2017), where knock-down resulted in a reduced progenitor pool and 321 
diminished neurogenesis. Though we also observed reduced neurogenesis we found, in 322 
contrast to Vancamp et al., that MCT8 was critical for later stages of the adult hippocampal 323 
program in the mouse, i.e. the differentiation step from NBs to INs, and not for the regulation 324 
of progenitor proliferation and pool size. This emphasizes that the mechanisms by which TH 325 
signalling influences neurogenic processes vary between niches. Similarly, a different function 326 
of the TH signal is documented in a third niche, the adult SVZ, where in contrast to the SGZ 327 
T3/TRα1 signalling is involved in repressing NSC pluripotency and determining the progenitor 328 
pool size (Remaud et al., 2014).  329 
The organotypic hippocampal slice culture system that we established is likely to have 330 
significant utility. Our protocol that allows adult slices to be maintained for up to 3 weeks 331 
enables examination of all stages of adult neurogenesis and cell-fate monitoring of EdU+ cells. 332 
We used the technique to show that application of the MCT8-specific inhibitor Silychristin 333 
compromised generation of EdU+/NEUN+ neurons after 3 weeks in culture without effects on 334 
EdU incorporation at earlier stages. This is in line with earlier in vivo studies of hypothyroid 335 
rodents that reported either no effect or only a slightly reduced progenitor proliferation of in the 336 
SGZ whereas formation of new neurons was impaired (Ambrogini et al., 2005; Desouza et al., 337 
2005; Montero-Pedrazuela et al., 2006). In comparison, application of the LAT-inhibitor BCH 338 
or the deiodinase inhibitor iopanoic acid did not alter neurogenesis in hippocampal slices. 339 
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These findings underscore a prominent gate-keeper role of MCT8 in NBs and substantiate the 340 
view that in the SGZ TH predominantly acts on post-mitotic progenitors (Remaud et al., 2014). 341 
  To define a mechanism by which MCT8 in NBs is required for proper differentiation we 342 
investigated the expression of cell cycle/CDK inhibitors P21CIP1, P27KIP1 and P57KIP2.  In 343 
line with recent work (Horster et al., 2017) we found pronounced P27 expression in SGZ NBs 344 
and INs of Wt mice whereas significantly lower P27 protein and mRNA levels were detected 345 
in MCT8ko and MCT8-NSCko mice. Based on that and reports showing p27 as a TH-target 346 
gene (Garcia-Silva et al., 2002; Holsberger et al., 2003), we speculate that absence of MCT8 347 
in NBs causes TH deficiency within the cells which in turn reduces the expression of P27 and 348 
inhibits differentiation. Consistent with this, P27 deficient mice have more proliferating cells in 349 
the SGZ, reduced levels of neurogenesis and specific cognitive impairments (Horster et al., 350 
2017).  351 
Our demonstration that in the CNS loss of MCT8 causes both cell autonomous and 352 
non-cell autonomous effects on neurogenesis will inform potential treatment strategies for 353 
AHDS where, in addition to any transport impairments across the BBB, effects of MCT8 loss 354 
in CNS cell populations will need to be addressed. Our findings also have important 355 
implications for therapeutic approaches addressing cognitive decline resulting from 356 
compromised hippocampal neurogenesis, where selective targeting of the cell autonomous 357 
functions of TH signalling may allow enhanced neuronal differentiation without the systemic 358 
effects of increased TH action.    359 
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Experimental Procedures 360 
 361 
Animals 362 
 MCT8ko mice obtained from Deltagen were generated, bred and genotyped as 363 
described previously (Trajkovic et al., 2007). Mct8fl mice obtained from the KOMP repository 364 
(Slc16a2tm1a(KOMP)Wtsi) were generated and genotyped as reported before (Mayerl et al., 2018). 365 
Mct8 +/ko and Mct8 +/fl females were bred with males (C57BL/6) carrying a Tamoxifen-366 
inducible Cre recombinase driven by the Nestin promoter (Lagace et al., 2007)  and a Cre 367 
reporter allele consisting of a loxP-flanked STOP cassette preventing transcription of a CAG 368 
promotor driven tdTomato construct (Madisen et al., 2010) purchased from Jackson 369 
laboratories (C57BL/6-Tg[Nes-cre/ERT2]KEisc/J, Jax stock #016261 and B6.Cg-370 
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze, Jax stock #007909). Cre and tdTomato (hereafter Rfp) 371 
transgenes were detected as described (Lagace et al., 2007; Madisen et al., 2010). At the age 372 
of 4-5 weeks, tamoxifen (180 mg/kg; Sigma-Aldrich) was administered to Mct8 +/y, Mct8 ko/y 373 
and Mct8 fl/y male mice (note that the Mct8 gene is located on the X-chromosome) harbouring 374 
both transgenes by oral gavage for 5 consecutive days and animals were kept for 5 months. 375 
For EdU labelling studies, mice (aged 2 or 6 months) were injected i.p. with 100 µl EdU (10 376 
mg/ml; Thermo Fisher) in PBS 3 d or 28 d before sacrifice. 6-8 week old mice for hippocampal 377 
slice cultures were injected twice with EdU as above 4 h and 2 h before sacrifice. 378 
Mice were kept at constant temperature (22 C) on a 12 h light, 12 h dark cycle and 379 
provided with standard chow and water ad libitum. Animals used for FACS studies were 380 
sacrificed by cervical dislocation at 2 months of age. For immunofluorescence studies mice 381 
were transcardially perfused with 4% PFA. Brains were cryo-protected with 30% sucrose, snap 382 
frozen in isopentane on dry ice and kept at -80 C. Mice designated for hippocampal slice 383 
culture were exposed to rising concentrations of CO2 and brains were isolated rapidly. For all 384 
studies, male mice have been used.  385 
 386 
FACS 387 
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For one run, brains of 8 C57BL/6N Wt mice were isolated, stored in chilled Hibernate 388 
A (Thermo Fisher) and dentate gyri were micro-dissected (Babu et al., 2011). Tissue was 389 
pooled and processed as described (Guez-Barber et al., 2012) and as summarised in the 390 
supplementary material.  391 
Before fixation, cells were re-suspended in Hibernate A, incubated for 15 min with a 392 
fixable live/dead cell stain (LIVE/DEAD® Fixable Violet Dead Cell Stain Kit; 1:000; Life 393 
Technologies) at 4 C and pelleted by centrifugation at 4000 rpm for 4 min. For fixation, cells 394 
were re-suspended in 1 ml chilled Hibernate A, 3 ml of ice-cold 100% Ethanol (molecular 395 
grade; Sigma-Aldrich) was added, and cells were fixed in this 75% Ethanol solution at 4 C for 396 
20 min (Diez et al., 1999). To increase mRNA yield and quality, all solutions used after this 397 
step were treated overnight with 1:1000 diethyl pyrocarbonate (Sigma-Aldrich) (Diez et al., 398 
1999). After fixation, cells were pelleted as above and washed in 1 ml chilled PBS containing 399 
0.1% saponin (Sigma-Aldrich), 0.2% BSA (Sigma-Aldrich) and 1:100 RNase inhibitor 400 
(RNaseOUT; Life Technologies) (Hrvatin et al., 2014). Staining procedures are detailed in the 401 
supplementary material.  402 
Hippocampal neurogenic populations were sorted with a FACS Aria II (BD Bioscience) 403 
into chilled RNase-free tubes containing 100 µl FACS buffer. All marker-negative cells were 404 
collected separately for RNA quality determination. If the final volume per tube exceeded 300 405 
µl, cells were pelleted by centrifugation for 10 min at 13200 rpm and 4 C. Cells were frozen on 406 
dry ice and stored at -80 C.  407 
 408 
Adult hippocampal slice culture 409 
Mouse brains were isolated and transferred into chilled dissection buffer (Hibernate A 410 
with 2% B27 supplement (Life Technologies), 2 mM L-Glutamine and 1% 411 
Penicillin/Streptomycin) on ice as described (Kim et al., 2013). Tissue was sectioned as 412 
published previously (Kleine Borgmann et al., 2013) in chilled dissection buffer using a 413 
vibratome. 300 µm sections were stored in dissection buffer on ice and transferred onto Millicell 414 
inserts (Millipore). Organotypic slices were cultured at 37 C and 5% CO2 in a serum-free 415 
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medium (Kim et al., 2013) (Neurobasal A (Life Technologies) containing 2% B27 supplement, 416 
2 mM L-Glutamine, 1% Penicillin/Streptomycin and 80 µM Indomethacin (Sigma-Aldrich)). 417 
During the entire culture period slices were exposed to 25 µM Silychristin (Sigma-Aldrich), 10 418 
µM iopanoic acid (Sigma-Aldrich), 1 mM BCH (R&D systems) or respective volumes of the 419 
solvents DMSO or culture medium as control. Culture medium was replaced every other day 420 
and slices were fixed for 1 h in 4% PFA.     421 
 422 
Immunofluorescence studies, Quantification and RT-PCR  423 
Procedures are described in the supplementary material. 424 
 425 
qPCR 426 
Total RNA from FACsorted hippocampal populations and respective controls was 427 
isolated using the RNEasy Micro Kit (Qiagen). RNA quality was assessed in controls on a high 428 
sensitivity screen tape (Agilent Technologies). At least 100.000 cells from control sorts were 429 
subjected to RIN value assessment. Samples were only processed further if RIN≥7. Two 430 
rounds of RNA amplification were conducted using the ExpressArt C&E PICO RNA 431 
Amplification kit (AMS Biotechnology) following the manufacturer’s instructions. RNA 432 
concentration was analysed with a RNA screentape (Agilent Technologies). If necessary, a 433 
third round of RNA amplification was performed and quantity was measured as before. 250 ng 434 
of RNA were subjected to cDNA synthesis using the SuperScript First-Strand Synthesis 435 
System (Invitrogen). Quantitative Real-Time PCR (qPCR) was performed using the QuantiFast 436 
SYBR Green PCR Kit (Qiagen) and the LightCycler® 480 system (Roche). Further information 437 
can be found in the supplementary material.  438 
 439 
Statistics 440 
All data represent mean+SEM. In slice culture experiments, to compare Wt vs. MCT8ko 441 
animals and control vs. MCT8-NSCko mice statistical significance between groups was 442 
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determined by unpaired two-tailed Student’s t test. Differences were considered significant 443 
when P < 0.05 and marked as follows: *, P < 0.05; **, P < 0.01; ***, P < 0.001. 444 
 445 
Study approval 446 
 All studies were executed in compliance with UK Home Office regulations and local 447 
guidelines by The University of Edinburgh.   448 
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Fig.1: Alterations in mRNA expression of TH signalling components during adult 603 
hippocampal neurogenesis. 604 
Micro-dissected dentate gyri were subjected to FACS and neurogenic/neuronal populations 605 
were sorted according to their expression of intracellular markers. A)  Schematic 606 
representation of the hippocampal neurogenic program illustrating expression of stage-specific 607 
markers used for sorting and validation strategies. B) qPCR analysis of neurogenic markers 608 
showing that isolated populations are of the expected identity. Relative mRNA expression of 609 
(C) TH transporters, (D) TH receptor isoforms, and (E) accessory proteins are depicted. 610 
Transcript levels were normalised to Gapdh expression and transcript expression in GCN. 611 
Note that due to their absence from GCN samples, Hes5 and Lat1 values were normalised to 612 
NSC levels while Dcx expression was normalised to NB values. n=2-4 individual samples per 613 
cell population.  614 
 615 
Fig.2: Spatiotemporal protein expression of TH signalling components. 616 
A) Perfusion-fixed coronal forebrain cryosections were immunostained to visualize DIO3, 617 
LAT1, LAT2, MCT8, and MCT10 protein (green) in the SGZ in GFAP+ (magenta)/SOX2+ (blue) 618 
NSCs, in MCM2+ (magenta) proliferating cells, in DCX+ (magenta) cells either negative for CR 619 
(type 2b progenitors and NBs) or CR+ (blue; INs), and in CB+ (magenta) GCNs. Nuclei were 620 
stained with Hoechst33258 (grey). B) MCT8 (green) co-stained with MCM2 (blue) in DCX+ 621 
(magenta; arrowhead) but not DCX- (*) cells. Cell nuclei counterstained by Hoechst33258 are 622 
displayed in grey. C) Distribution of DIO3, LAT2, MCT8, and MCT10 (green) over the height 623 
of the suprapyramidal blade of the dentate gyrus. Nuclei were stained for Hoechst33258 (grey) 624 
and mature GCNs were identified by CB (magenta). DIO3 and LAT2 protein are asymmetrically 625 
distributed with higher signal intensities in areas close to the molecular layer while MCT8 and 626 
MCT0 appear evenly dispersed.  627 
 628 
Fig.3: Inhibition of MCT8 in adult slices perturbs neuron formation. 629 
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After acute EdU injection, adult brain slices cultured ex vivo for up to 3 weeks. Lineage 630 
progression in the presence of TH signalling inhibitors was assessed. A) Exemplar pictures 631 
from adult slices grown in control medium. EdU incorporation (magenta) into proliferating cells 632 
(KI67+, green) was visualised after 1 day; into DCX+ cells (type 2b progenitors, NBs and INs) 633 
after 7 days; and into newly formed neurons (NEUN positive, green) after 21 days. 634 
Hoechst33258-counterstained nuclei are shown in blue. Total number of EdU+ cells (B) and 635 
incorporation of EdU into KI67+ cells (C) after 1 day in culture, EdU+/DCX+ cells at Day7 (D) 636 
and newly formed neurons (EdU+/NEUN+) at Day21 (E) upon exposure to 25 µM Silychristin 637 
were quantified. n=4-6 mice per condition.   638 
 639 
Fig.4: Adult hippocampal neurogenesis is altered in 2 months old MCT8ko mice. 640 
Perfusion-fixed cryosections of 2-month-old Wt and MCT8ko littermates were immunostained 641 
for stage-specific markers of hippocampal neurogenesis. A) Total numbers of GFAP+(cyan) 642 
and SOX2+(yellow) NSCs (arrowheads) harbouring a single process protruding into the 643 
granule cell layer, and activated NSCs (KI67+; magenta; arrows). B) Overall numbers of 644 
proliferating cells in the SGZ (all KI67+ cells; green; arrowheads) and numbers of proliferating 645 
type 2b/NBs expressing KI67 and DCX (magenta; arrows). C) DCX(magenta) and CR(green) 646 
were used to discriminate between type 2b progenitors/NBs (only DCX+; arrows) and INs 647 
(DCX+/CR+, arrowheads). D) Timeline of EdU labelling experiments. Injected at P60, mice 648 
were perfused 3 d or 28 d later and stained as shown. E) EdU(cyan) retention in proliferating 649 
progenitors (KI67+; yellow; arrowheads) and DCX+ (magenta; arrows) cells was assessed at 650 
3 dpi. F) Incorporation of EdU (cyan) into type 2b progenitors/NBs (DCX+ (magenta)/CR- 651 
(yellow); arrows) and into INs (DCX+/CR+; arrowheads). G) 28 days after EdU pulse, GCN 652 
formation (CB+(green) and EdU(magenta)) was analysed. In all experiments, cell nuclei were 653 
counter-stained with Hoechst33258 (blue). n=4 (28 dp EdU) or n=6 (3 dp EdU) mice per 654 
genotype. 655 
 656 
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Fig.5: MCT8 deficiency compromises adult hippocampal neurogenesis at 6 months of 657 
age. 658 
Neurogenesis was assessed in 6-month-old males. A) Numbers of GFAP+ (cyan)/SOX2+ 659 
(yellow) NSCs with a radial process (arrowheads) as well as density of activated KI67+ 660 
(magenta, arrow) NSCs. B) Proliferation 3 d after EdU injection. Overall KI67+ (cyan; arrows) 661 
and KI67+/EdU+ (yellow) cell numbers are shown. Late stage proliferating cells expressing 662 
DCX (magenta, arrowheads) show a higher proliferative capacity. C) Density of DCX+ 663 
(magenta)/CR- (cyan) type 2b progenitors/NBs (arrowheads) as well as of DCX+/CR+ INs 664 
(arrows) with or without EdU (3 dpi; yellow). D) Newly formed GCNs (arrowheads) positive for 665 
CB (green) and EdU (magenta) were visualised 28 d after EdU injection. E) Breeding strategy 666 
to generate males harbouring the Wt or Mct8ko allele as well as Nestin-CreERT2 and Rfp 667 
reporter transgenes. Animals were gavaged for 5 consecutive days at 4 weeks of age and 668 
perfused at 6 months of age. F) Numbers of GFAP+(cyan)/SOX2+(yellow) NSCs (arrows) with 669 
a radial process and of RFP+ (in magenta, arrowheads) NSCs were counted and quantified 670 
as per mm and % of RFP+ cells. G) RFP+ (magenta)/ CB+ (green) GCNs (arrowheads) were 671 
counted and normalised to the number of RFP+ cells. Cell nuclei were stained with 672 
Hoechst33258 (blue). n=4 (28 dp EdU and Nestin-Cre; Rfp animals) or n=6 (3 dp EdU injection) 673 
mice per genotype. 674 
     675 
Fig.6: Absence of MCT8 in NSCs compromises adult hippocampal neurogenesis. 676 
A) Mct8fl/+ females were bred with males carrying Nestin-CreERT2 and Rfp reporter alleles to 677 
generate Mct8+/y, Nestin-CreERT2, Rfp (control) and Mct8fl/y, Nestin-CreERT2, Rfp (MCT8-678 
NSCko) littermates. Tamoxifen was given for 5 consecutive days at 4 weeks of age and 679 
animals were perfused at 6 months of age. B) Number of RFP+ (magenta)/GFAP+ 680 
(yellow)/SOX2+ (cyan) NSCs per mm SGZ and their % contribution to all RFP+ cells were 681 
determined. C-F) Relative numbers of RFP+ (magenta; arrowheads)-labelled activated NSCs 682 
(KI67+(yellow)/GFAP+(cyan)) (C), proliferating cells (KI67+; cyan) and proliferating 683 
DCX+(yellow) cells (D), apoptotic cells (CASPASE3+; green) (E), DCX+(cyan)/CR-(yellow) 684 
 28 
type 2b progenitors/NBs and RFP+/DCX+/CR+ INs (arrows) (F). (G) Ratio of RFP+ 685 
(magenta)/CB+ (green) GCNs (arrowheads) over all RFP+ cells. Hoechst33258 labelled cell 686 
nuclei are depicted in blue. n=5 mice per genotype. 687 
 688 
Fig.7: Cell cycle inhibitor expression is altered in MCT8 deficiency. 689 
A) Representative overview images and magnified views of P27KIP1(green) staining in DCX+ 690 
(magenta) type 2b progenitors/NBs and DCX+/CR+(blue) INs at 2 months of age. Normalised 691 
nuclear P27 fluorescent signal intensities were quantified. B) P27 immunoreactivity in type 2b 692 
progenitors/NBs and INs was measured at 6 months of age. C) Sections from 6-month-old 693 
MCT8-NSCko and control brains were stained for P27KIP1(green), DCX(blue) and CR(grey). 694 
RFP fluorescence is shown in magenta. Magnified views depict CR-/RFP+/DCX+ cells. 695 
Normalised P27 signal intensities were compared. D, E) P21(green) was analysed at 2 months 696 
(D) and 6 months of age (E). F, G) P57 (in green) fluorescence intensities were assessed at 2 697 
months (F) and 6 months (G) of age. Hoechst33258 positive nuclei are shown in grey, DCX in 698 
magenta and CR in blue. n=6 (A, B, D-G) and n=4-5 (C) mice per genotype. 699 
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